Edap Tms . News (NASDAQ:EDAP)
| Latest Edap Tms . News Headlines | | Date | Time | Source | | | 10/30/2007 | 12:29PM | PRNUS | EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies
LYON, France, Oct. 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces that it has entered into a securities purchase agreement with selected United States based qualified institutional buyers ("Investors") pursuant to... More...>> |
| 09/10/2007 | 9:49AM | PRNUS | EDAP Launches Enhanced Communication Plans at SIU Paris Congress
Ablatherm-HIFU Marketing Programs Help Surgeons Go the Extra Mile for Patients
LYON, France, Sept. 10 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and a major global provider of stone breaking products, launched its... More...>> |
| 08/30/2007 | 7:45AM | PRNUS | EDAP TMS S.A. to Release 2007 Second Quarter Results
LYON, France, Aug. 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide portfolio of minimally invasive medical devices primarily for... More...>> |
| 08/30/2007 | 7:30AM | PRNUS | EDAP TMS S.A. 2007 Second Quarter Revenues Increase
European Growth Continues, HIFU Division Returns to Profitability
LYON, France, Aug. 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a... More...>> |
| 08/17/2007 | 11:04AM | PRNUS | EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
LYON, France, Aug. 17 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, is currently conducting clinical investigations in France under an approved clinical trial combining the company's Ablatherm-HIFU device with chemotherapy... More...>> |
| 08/16/2007 | 6:06PM | PRNUS | EDAP TMS S.A. to Release 2007 Second Quarter Results
LYON, France, Aug. 16 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide portfolio of minimally invasive medical devices primarily for... More...>> |
| 07/23/2007 | 10:29AM | PRNUS | EDAP Reports Three New RPP Sites in New German Regions
PR Marketing & Education Programs to Expand
LYON, France, July 23 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, continues to penetrate the German HIFU market. Recent activities including the company's successful HIFU... More...>> |
| 07/16/2007 | 9:20AM | PRNUS | EDAP Revises Termination Agreement With HealthTronics
LYON, France, July 16 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, reports today an update to its Termination Agreement with HealthTronics, Inc.
On July 9, 2007, EDAP TMS S.A. entered into a letter agreement with HealthTronics... More...>> |
| 07/11/2007 | 2:09PM | PRNUS | EDAP Continues Ablatherm-HIFU Training Program for US Investigators
Dedicated Press Conference Organized at Edouard Herriot Hospital, Lyon, France
LYON, France, July 11 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, continued its media and education campaigns in major European markets... More...>> |
| 06/28/2007 | 9:20AM | PRNUS | EDAP Appoints Dr. John C. Rewcastle as International Medical Director
Strong North American Focus, Expertise to Augment US Study Program
LYON, France, June 28 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announces the appointment of Dr. John C. Rewcastle as International Medical Director... More...>> |
| 06/27/2007 | 3:06PM | PRNUS | EDAP Achieves 7% Share in French Public Market Prior to Reimbursement
Official Report Ranks Ablatherm-HIFU User Sites Among Top French Public Hospitals
LYON, France, June 27 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, continues French progress ahead of reimbursement approval. Ablatherm-HIFU... More...>> |
| 06/26/2007 | 2:14PM | PRNUS | EDAP TMS S.A. Adds Global Distribution of LMA StoneBreaker(TM) System
EDAP Adds Malaysia, Korea to France as Exclusive Markets and Secures Worldwide Exclusivity When StoneBreaker(TM) Offered with EDAP's Devices
LYON, France, June 26 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and provider... More...>> |
| 06/20/2007 | 10:25AM | PRNUS | New Ablatherm(R)-HIFU Site Launched in the United Kingdom
First UK Fixed Revenue-Per-Procedure Service Available at Capio Springfield Hospital
LYON, France, June 20 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announces the introduction of fixed Ablatherm(R)-HIFU services... More...>> |
| 06/18/2007 | 11:53AM | PRNUS | EDAP Ablatherm-HIFU Strongly Highlighted in European Congresses
LYON, France, June 18 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, reports continued and sustained marketing presence in various European events to grow Ablatherm-HIFU market penetration all over Europe.
In the month... More...>> |
| 06/05/2007 | 9:56AM | PRNUS | EDAP to Add University of Colorado Under Direction of Dr. David Crawford to Clinical Study
LYON, France, June 5 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, intends to add the University of Colorado Health Sciences Center at Denver, to its US study participating sites. Dr. E. David Crawford, M.D., Professor... More...>> |
| 06/01/2007 | 10:58AM | PRNUS | EDAP Looking to Accelerate US Study Enrollment With the Upcoming Addition of McMaster University Hospital
LYON, France, June 1 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, reports further intentions to accelerate its clinical trial study enrollment with the upcoming addition of the McMaster University Hospital near Toronto... More...>> |
| 05/23/2007 | 7:59AM | PRNUS | EDAP Ablatherm-HIFU Presents at American Urology Association Accelerates US Study Enrollment
LYON, France, May 23 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, reports the continuing advancement of its clinical trial and education programs at the American Urology Association Congress in Anaheim May 19-22, 2007... More...>> |
| 05/22/2007 | 10:10AM | PRNUS | EDAP Fast-Tracks U.S. Clinical Trial for Non-Invasive Prostate Cancer
Long-Term European Results Highlight the Importance of This Study for U.S.
LYON, France, May 22 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer is fast-tracking its ongoing U.S. Ablatherm(R)- HIFU clinical trial. Long-term... More...>> |
| 05/17/2007 | 2:20PM | PRNUS | Ablatherm-HIFU Adoption Growing Across Europe
European Marketing and Education Strategy Validated
LYON, France, May 17 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, updates shareholders on continued success of its marketing rollout across major European markets... More...>> |
| 05/10/2007 | 4:34PM | PRNUS | EDAP TMS S.A. Reports 2007 First Quarter Results; Ablatherm-HIFU Treatments Grow
European RPP Program on Target for 2008 Profitability; FDA Trial Launch Positions EDAP for Direct USA Control; EDAP, China Medical Alliance Unites HIFU Leaders
LYON, France, May 10 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate... More...>> |
|
|
|